34762 Adjuvant pembrolizumab versus placebo in high-risk locally advanced cutaneous squamous cell carcinoma: The phase 3 KEYNOTE-630 study

Autor: Michael Schenker, Mikhail Klochikhin, Ase Bratland, Dmitry Kirtbaya, Alexander Guminski, Marcin Dzienis, Chrysalyne Schmults, Joy Y. Ge, Jianda Yuan, Jenny Lee
Rok vydání: 2022
Předmět:
Zdroj: Journal of the American Academy of Dermatology. 87:AB135
ISSN: 0190-9622
DOI: 10.1016/j.jaad.2022.06.574
Databáze: OpenAIRE